Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Active, not recruiting · NCT03890614 · Registry updated 2026-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Not stated | 2026-08-06 | NCT03890614 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Wake Forest University Health Sciences | 284 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | United States | 26 |